Investors sold shares of Medtronic Inc. (NYSE:MDT) on strength during trading on Monday. $40.89 million flowed into the stock on the tick-up and $74.06 million flowed out of the stock on the tick-down, for a money net flow of $33.17 million out of the stock. Of all stocks tracked, Medtronic had the 0th highest net out-flow for the day. Medtronic traded up $0.37 for the day and closed at $87.91

Several analysts have weighed in on the company. Bank of America Corp. reissued a “buy” rating on shares of Medtronic in a report on Sunday, May 22nd. Vetr raised Medtronic from a “buy” rating to a “strong-buy” rating and set a $89.50 price objective for the company in a report on Monday, May 2nd. BTIG Research cut Medtronic from a “buy” rating to a “neutral” rating and set a $82.00 price objective for the company. in a report on Tuesday, May 31st. Zacks Investment Research cut Medtronic from a “hold” rating to a “sell” rating in a report on Tuesday, May 3rd. Finally, Needham & Company LLC reissued a “buy” rating on shares of Medtronic in a report on Monday, June 27th. Six investment analysts have rated the stock with a hold rating and nineteen have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $88.50.

The firm has a market cap of $121.86 billion and a price-to-earnings ratio of 35.232. The firm’s 50 day moving average price is $87.40 and its 200-day moving average price is $80.73.

Medtronic (NYSE:MDT) last issued its earnings results on Tuesday, May 31st. The medical technology company reported $1.27 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.26 by $0.01. During the same quarter in the previous year, the firm posted $1.16 earnings per share. The business earned $7.57 billion during the quarter, compared to the consensus estimate of $7.49 billion. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. On average, equities analysts expect that Medtronic Inc. will post $4.66 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 27th. Shareholders of record on Friday, July 8th were issued a $0.43 dividend. The ex-dividend date of this dividend was Wednesday, July 6th. This represents a $1.72 dividend on an annualized basis and a yield of 1.96%. This is a boost from Medtronic’s previous quarterly dividend of $0.38.

In other Medtronic news, VP Richard Kuntz sold 49,905 shares of Medtronic stock in a transaction that occurred on Friday, June 3rd. The stock was sold at an average price of $82.60, for a total value of $4,122,153.00. Following the completion of the sale, the vice president now directly owns 127,647 shares in the company, valued at $10,543,642.20. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Carol A. Surface sold 9,787 shares of Medtronic stock in a transaction that occurred on Wednesday, July 6th. The stock was sold at an average price of $87.08, for a total value of $852,251.96. The disclosure for this sale can be found here.

Several large investors have recently added to or reduced their stakes in the stock. SVA Plumb Wealth Management LLC increased its stake in Medtronic by 0.5% in the fourth quarter. SVA Plumb Wealth Management LLC now owns 44,808 shares of the medical technology company’s stock valued at $3,447,000 after buying an additional 235 shares in the last quarter. Tredje AP fonden increased its stake in Medtronic by 35.1% in the fourth quarter. Tredje AP fonden now owns 47,480 shares of the medical technology company’s stock valued at $3,670,000 after buying an additional 12,335 shares in the last quarter. Wells Fargo & Company MN increased its stake in Medtronic by 2.0% in the fourth quarter. Wells Fargo & Company MN now owns 13,110,194 shares of the medical technology company’s stock valued at $1,008,436,000 after buying an additional 253,096 shares in the last quarter. Principal Financial Group Inc. increased its stake in Medtronic by 1.5% in the fourth quarter. Principal Financial Group Inc. now owns 1,841,019 shares of the medical technology company’s stock valued at $141,611,000 after buying an additional 27,459 shares in the last quarter. Finally, WFG Advisors LP increased its stake in Medtronic by 0.5% in the fourth quarter. WFG Advisors LP now owns 18,417 shares of the medical technology company’s stock valued at $1,417,000 after buying an additional 88 shares in the last quarter.

Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.